Get the Stockscreener App
0.808
42.39%
0.2369
Liminatus Pharma Inc stock is traded at $0.808, with a volume of 19.10M.
It is up +42.39% in the last 24 hours and up +26.92% over the past month.
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
See More
Previous Close:
$0.5711
Open:
$0.6782
24h Volume:
19.10M
Relative Volume:
39.37
Market Cap:
$21.74M
Revenue:
-
Net Income/Loss:
$-1.40M
P/E Ratio:
-3.8959
EPS:
-0.2074
Net Cash Flow:
$-10.49M
1W Performance:
+24.23%
1M Performance:
+26.92%
6M Performance:
-86.29%
1Y Performance:
+0.00%
1-Day Range:
$0.6327
$0.85
1-Week Range:
$0.5399
$0.85
52-Week Range:
$0.5399
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Name
Liminatus Pharma Inc
Sector
Industry
Phone
213-273-5453
Address
6 CENTERPOINTE DR., LA PALMA
Compare LIMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.8031 | 15.46M | 0 | -1.40M | -10.49M | -0.2074 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.13 | 119.76B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
757.67 | 79.35B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
848.34 | 51.71B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
345.50 | 44.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
344.18 | 38.18B | 4.98B | 69.60M | 525.67M | 0.5198 |
Liminatus Pharma Inc Stock (LIMN) Latest News
Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares - TechStock²
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Teradyne Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Valuation Update: Is Riverview Bancorp Inc a turnaround story2025 Historical Comparison & AI Forecast Swing Trade Picks - baoquankhu1.vn
Take Profit: Is Booking Holdings Inc a potential multi baggerJuly 2025 Snapshot & Long-Term Capital Growth Ideas - baoquankhu1.vn
Gains Report: Will Quanex Building Products Corporation benefit from sector rotation2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
What is Liminatus Pharma Inc. Equity Warrant’s market position2025 Price Action Summary & Long-Term Capital Growth Ideas - Mfd.ru
Institution Moves: Is now the right time to enter Liminatus Pharma Inc Equity WarrantMarket Trend Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Nasdaq Moves: What is the earnings history of ESGL Holdings Limited Equity Warrant2025 Breakouts & Breakdowns & Stepwise Trade Signal Implementation - baoquankhu1.vn
Market Fear: Is RFAIU exposed to currency risksJuly 2025 EndofMonth & Breakout Confirmation Trade Signals - baoquankhu1.vn
Valuation Update: What are the future prospects of Liminatus Pharma Inc Equity Warrant2025 Biggest Moves & Weekly Return Optimization Plans - baoquankhu1.vn
Signal Recap: What are the risks of holding Cyclacel Pharmaceuticals IncWeekly Investment Summary & Daily Momentum Trading Reports - baoquankhu1.vn
Liminatus Pharma Faces Nasdaq Bid Price Compliance Challenge - TipRanks
Liminatus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Shorts Report: Is TBMC stock trending bullishQuarterly Trade Review & Weekly Top Stock Performers List - baoquankhu1.vn
Market Leaders: Whats next for Channel Therapeutics Corporation stock2025 Stock Rankings & Daily Stock Trend Reports - baoquankhu1.vn
Trading Action: Will Liminatus Pharma Inc outperform its industry peersWeekly Investment Report & Capital Efficiency Focused Strategies - baoquankhu1.vn
New Highs: Can Liminatus Pharma Inc sustain its profitabilityWeekly Profit Recap & AI Driven Stock Movement Reports - baoquankhu1.vn
Bearish Setup: Is Embecta Corp forming a double bottomMarket Performance Report & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Aug Momentum: Is A19QHVs growth already priced inJuly 2025 Macro Moves & Verified Swing Trading Watchlist - baoquankhu1.vn
Quarterly Earnings: Is Liminatus Pharma Inc stock risky to hold nowJuly 2025 Retail & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Bull Run: Can Liminatus Pharma Inc sustain its profitabilityJuly 2025 Action & Verified Technical Trade Signals - baoquankhu1.vn
Trading Action: Is UONEK stock a value trapMarket Performance Summary & Consistent Profit Alerts - baoquankhu1.vn
Gains Recap: Is Citigroup Capital XVI Preferred Security stock undervalued right nowInsider Buying & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Momentum Shift: How liquid is Liminatus Pharma Inc stockTrade Analysis Report & Real-Time Market Sentiment Alerts - baoquankhu1.vn
FOMO Trade: How is Roadzen Inc managing supply chain issuesMarket Risk Report & Safe Capital Growth Plans - baoquankhu1.vn
Will Liminatus Pharma Inc stock attract more institutional investorsWall Street Watch & Safe Capital Allocation Plans - Bộ Nội Vụ
Support Test: Will Liminatus Pharma Inc stock attract more institutional investors - Bộ Nội Vụ
Pullback Watch: Why is DATSW stock going downJuly 2025 Rallies & Low Risk Growth Stock Ideas - baoquankhu1.vn
Options Flow: Is Liminatus Pharma Inc a strong growth stockEarnings Risk Report & Daily Profit Focused Stock Screening - baoquankhu1.vn
Aug Volume: Can Liminatus Pharma Inc. Equity Warrant stock hit record highs again2025 Technical Overview & Smart Swing Trading Techniques - ulpravda.ru
What Wall Street predicts for Liminatus Pharma Inc. stock priceJuly 2025 Selloffs & Accurate Intraday Trading Signals - ulpravda.ru
Can PLMKW stock deliver surprise earnings beatQuarterly Performance Summary & Trade Opportunity Analysis - Улправда
What insider trading reveals about Liminatus Pharma Inc. stockWeekly Trend Summary & Smart Investment Allocation Insights - Улправда
How FOUR stock reacts to bond yieldsWeekly Gains Report & Expert-Curated Trade Recommendations - Улправда
Starlog Enterprises Limited Stock Approaches Key Moving AverageMarket Sentiment Report & Real-Time Stock Price Movement Reports - Улправда
Is Liminatus Pharma Inc. Equity Warrant stock oversold or undervaluedJuly 2025 Trends & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Will Liminatus Pharma Inc. stock see insider buying2025 Year in Review & Smart Investment Allocation Insights - Улправда
Will Liminatus Pharma Inc. stock benefit from AI adoptionJuly 2025 Big Picture & Real-Time Buy Signal Notifications - ulpravda.ru
Growth Value: Can Liminatus Pharma Inc. stock beat market expectations this quarterJuly 2025 Drop Watch & Detailed Earnings Play Alerts - Улправда
Published on: 2026-01-09 01:14:45 - Улправда
Is Liminatus Pharma Inc. stock affected by interest rate hikesJuly 2025 Summary & Risk Adjusted Buy and Sell Alerts - Улправда
Why analysts remain bullish on Veris Residential Inc. stockTake Profit & AI Enhanced Market Trend Forecasts - Улправда
Is Liminatus Pharma Inc. stock oversold or undervaluedJuly 2025 Recap & Daily Oversold Bounce Ideas - ulpravda.ru
Why analysts maintain buy rating on Universal Corporation stockEarnings Growth Summary & Verified Technical Trade Signals - Улправда
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Critical Survey: Liminatus Pharma (NASDAQ:LIMN) vs. Inhibikase Therapeutics (NASDAQ:IKT) - Defense World
Where Could Kokuyo Camlin Limited (523207) Be HeadedLow Beta Stocks & Free Expert Guidance For Growth - earlytimes.in
Comparing Liminatus Pharma (NASDAQ:LIMN) & Inhibikase Therapeutics (NASDAQ:IKT) - Defense World
Tamilnadu Petroproducts Limited Price Holds Above Key Fib LevelTrading Volume Trends & Small Entry Trading Portfolio - bollywoodhelpline.com
Inhibikase Therapeutics (NASDAQ:IKT) versus Liminatus Pharma (NASDAQ:LIMN) Head to Head Comparison - Defense World
Liminatus Pharma Inc Stock (LIMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):